We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
WBAG:NNO2
​
​
logo

Novo Nordisk A/S (NNO2)

WBAG • NNO2 • DK0062498333

36.59Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 124 days to cover, cost to borrow 1.56%. Sign up for live short interest data.

Market Cap

180b USD | # 94 in AT

Volume

6.12k shares | 7.25m USD

Shares Outstanding

3.33b

Free Float Shares

94.64% | 3.16b

NYSE:NVO|
OTCPK:NONO.F|
DB:NOV|
DB:NOV0|
DB:NOV1|
DB:NOVA|
XTRA:NOV|
LSE:0QIU|
LSE:0TDD|
TSX:NOVO|
BOVESPA:N1VO34|
BASE:NVO|
BASE:NVOD|
CPSE:NOVO B|
WSE:NVO|
SET:NOVOB80|
NEOE:NVON

News

NNO2 key data

Novo Nordisk A/S (WBAG: NNO2) has a market capitalization of $179.56B. Last close €36.59 (as of 2026-11-12); 52-week range €30.01 to €55.08. ORTEX data as of 2026-10-28: short interest was 0.02% of free float, 124 days to cover and the average cost to borrow was 1.56%. Sign up for live short interest data.

  • NNO2 news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.